David Moebius
12Patents
4h-index
48Co-inventors
56Inventor score
Filing activity: Jun 1, 2012 → Feb 15, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9434761B2 | Tripeptide epoxy ketone protease inhibitors | Human Necessities | 13 | Active |
| US11299479B1 | Bisamide sarcomere activating compounds and uses thereof | Emerging Cross-Sectional Technologies | 6 | Active |
| US10723720B2 | Bisamide sarcomere activating compounds and uses therof | Emerging Cross-Sectional Technologies | 5 | Active |
| US10899746B2 | Bisamide sarcomere activating compounds and uses thereof | Emerging Cross-Sectional Technologies | 4 | Active |
| US9657057B2 | Dipeptide and tripeptide epoxy ketone protease inhibitors | Human Necessities | 2 | Active |
| US10647744B2 | Tripeptide epoxy ketone protease inhibitors | Human Necessities | 1 | Active |
| US9321713B2 | Hyperforin analogs, methods of synthesis, and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11780826B2 | Bisamide sarcomere activating compounds and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US10689367B2 | Triazole pyridyl compounds as agonists of the APJ receptor | Human Necessities | 1 | Active |
| US11078233B2 | Tripeptide epoxy ketone protease inhibitors | Human Necessities | 0 | Active |
| USRE47302E1 | Peptide epoxyketone immunoproteasome inhibitors | General | 0 | Active |
| US11040981B2 | Pyrrolotriazine compounds and methods of inhibiting TAM kinases | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.